The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 27, 2025

Filed:

Apr. 21, 2022
Applicants:

University of Connecticut, Farmington, CT (US);

University of Notre Dame Du Lac, Notre Dame, IN (US);

Inventors:

Pramod K. Srivastava, Avon, CT (US);

Brian M. Baker, Granger, IN (US);

Assignees:

UNIVERSITY OF CONNECTICUT, Farmington, CT (US);

UNIVERSITY OF NOTRE DAME DU LAC, Notre Dame, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/00 (2006.01); C12Q 1/6869 (2018.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 39/395 (2013.01); C12Q 1/6869 (2013.01); C07K 2317/92 (2013.01);
Abstract

Described herein are methods of identifying immunologically protective neo-epitopes from the cancer tissue DNA of cancer patients using biophysical principles as well as bioinformatics techniques. The identification of immunologically protective neo-epitopes provides pharmaceutical compositions with a limited number of tumor-specific peptides suitable for personalized genomics-driven immunotherapy of human cancer. Specifically disclosed herein is a method of using the conformational stability of an epitope in an MHC protein-binding groove to predict immunogenicity of peptides in a putative neo-peptide set from a tumor from a cancer patient. Pharmaceutical compositions and methods of administration are also included.


Find Patent Forward Citations

Loading…